Researchers develop new vaccine against deadly Middle East Respiratory Syndrome

Researchers made two versions of a potential vaccine and evaluated their effectiveness and safety in mice that were genetically altered to have more human-like immune responses. After the mice were vaccinated and then infected with Middle East respiratory syndrome (MERS), both vaccines protected the mice against clinical signs of disease and death.

Johnson & Johnson Innovation and Children's National Health System* to Launch JLABS @ Washington, DC at the new Children's National Research and Innovation Campus in 2020

The US Biomedical Advanced Research and Development Authority (BARDA) collaborates with JLABS to stimulate innovation and incubation of technologies that improve health security and response through companies focused on public health threats and emerging infectious diseases.